Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns.

The test yielded a p-value of 7.00e-49, demonstrating that the overlap is highly significant and unlikely to be due to statistical chance (Fig. 2 B).

also in 132,142 other papers